Tafamidis
- Molecular formula
- C31H24F2N2O9
- CAS Number
- 603132-23-8
- IUPAC Name
- 3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid
- Molecular Weight
- 905.90g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.5103g/cm3
- Synonyms
- 3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3, 4-dihydroxy-2-oxolanyl]-2-purinyl]amino]ethyl]phenyl]propanoic acid
Identification
Interesting Facts about 3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid
This compound, often referred to in scientific literature as a novel pharmaceutical agent, is a complex molecule with a variety of intriguing features:
- Biological Significance: This compound has shown potential in biomedical applications, particularly in drug design aimed at targeting specific cellular pathways.
- Structural Complexity: Its intricate structure incorporates multiple functional groups, making it an interesting subject for studies in medicinal chemistry.
- Target Interactions: The unique configuration allows it to interact with various biological receptors, enhancing its efficacy in therapeutic scenarios, especially in cancer research.
- Synthetic Challenges: Synthesizing such a compound poses considerable challenges, typically requiring multiple reaction steps and careful control of conditions to ensure purity and yield.
As quoted by researchers in the field, “The synthesis and characterization of complex pharmaceuticals serve as the backbone of effective drug development.” This underscores the importance of compounds like 3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid in modern chemistry.
In conclusion, studying such compounds not only offers insights into molecular interactions but also fuels innovation in therapeutic strategies, making it a fascinating area of focus for both chemists and medical researchers alike.